PHARMA JOBS News, Sports, Shopping, Travel information

Are You Unemployed And Broke?
Answer A Simple Survey About Your Unemployment And Receive $500 Cash! You Might Just Even Get Yourself A Job Here!
www.Jobs.com

Update 2- Mds Slashes Outlook As It Slips To Loss - Reuters
toronto, sept 4 (reuters) - mds inc (mds.to: quote , profile , research , stock buzz ) reported weaker third-quarter results and slashed its full-year outlook on thursday as the health sciences company copes with slower than expected revenue at its ...
www.reuters.com

Charges And Pharma Results Push Mds To 3q Loss
canadian life sciences company mds inc. said it swung to a loss in the fiscal third quarter, as results at its pharma services business were disappointing and the company took a series of one-time charges.
biz.yahoo.com

Drug Maker To Cut Jobs In Norman
norman — astellas pharma technologies inc. is offering early retirement and a "voluntary termination plan” to its norman work force of 200 as part of a restructuring in advance of the expiration of a key drug patent. astellas anticipates the expiration of the flomax drug patent will reduce the production volume at the plant and hopes that up to 60 workers in norman will take the early retirement ...
newsok.com

Urgent - Medical Advisor - Female/reproductive Health - Circa £70k - Silicon.com
medical advisor – female health: a world leading global pharmaceutical company is looking to recruit an ambitious senior medical advisor to develop clinical trial plans, interpret data and provide medical support to the business. main ...
www.silicon.com

Mds Slashes Outlook As It Slips To Loss - Reuters Canada
toronto (reuters) - mds inc (mds.to: quote ) reported weaker third-quarter results and slashed its full-year outlook on thursday as the health sciences company copes with slower than expected revenue at its pharma services contract research division ...
ca.reuters.com

Mds Lowers Fiscal 2008 Expectations
mds inc., a canadian life sciences company, cut its fiscal 2008 profit and revenue outlooks thursday, as it expects weaker revenue from its pharma services revenue, and further restructuring costs.
biz.yahoo.com

Mds Slashes Outlook As It Slips To Loss
mds inc reported weaker third-quarter results and slashed its full-year outlook on thursday as the health sciences company copes with slower than expected revenue at its pharma services contract research division.
ca.news.yahoo.com

Biogen’s Battered Ms Drug In Cancer Treatment Trials - Mass High Tech
cambridge biotech biogen idec and irish drug partner elan corp. began testing their multiple sclerosis drug tysabri in a phase 2/3 trial for multiple myeloma. it is the first time the immune modulating drug, specifically a recombinant, humanized ...
www.masshightech.com

Former Red Sox Exec Swings For Fence At Trumedia - Mass High Tech
rafe anderson is a red sox fan to the bone. but while most boys grow up wanting to play for the team, his dream was to get in on the business side. and he did. the new president and ceo of trumedia networks llc , a company that designs online ...
www.masshightech.com

Mds Slashes Outlook As It Slips To Loss
toronto (reuters) - mds inc reported weaker third-quarter results and slashed its full-year outlook on thursday as the health sciences company copes with slower than expected revenue at its pharma services contract research division.
www.globeinvestor.com

All About Woodstock: Little-known Employers Have Big Impact
woodstock – many woodstock companies affect mchenry county and beyond.
www.nwherald.com

Mds Reports $10m Quarterly Loss, Cuts Revenue And Profit Guidance - News1130.com
toronto - facing what it sees as a soft market ahead, life sciences technology company mds inc. (tsx:mds) has cut its full-year revenue and profit outlook after dropping to a third-quarter net loss of $10 million. the loss in the quarter ended july ...
www.news1130.com

Outsourcing The Drug Industry - Businessweek
(page 2 of 3) the rush east, where five phd chemists can be had for the cost of one in the west, entails risks. at a time when pfizer ( pfe ), astrazeneca ( azn ), and others are slashing u.s. r&d jobs by the thousands, the buildup in asia is bound ...
www.businessweek.com

Outsourcing The Drug Industry
in her swank headquarters just blocks from some of mumbai's worst slums, swati piramal is midway through an impassioned pitch about revolutionizing the world of drug discovery. sanskrit passages of the bhagavad gita, the ancient hindu text that guides her business philosophy, adorn the office walls of her company, piramal life sciences. its logo is gyan mudra, a finger gesture used in yoga ...
news.yahoo.com

Us Outsourcing Drug Research To India
us giants are rushing to partner with indian and chinese companies—tapping their brainpower and saving millions of dollars in the search for breakthrough treatments
www.rediff.com

Europe Is Destination Next For Indian Professionals, Workers - Times Of India
new delhi: with the government pushing for a bilateral labour mobility agreement, indian professionals and workers may soon be headed for destinations in eastern european countries, as 13 million job opportunities are expected to arise there. with ...
timesofindia.indiatimes.com

Clinical Project Director - Medium Sized Cro *home Based* - Silicon.com
medium sized cro – breaking into top 10 having been established within the clinical industry for over 10yrs as a privately owned cro currently sitting in the top 15 cro’s in the world they are now looking to make that next step! working across ...
www.silicon.com

Economic Crisis Becoming Increasingly Broad-based
(rttnews) - trader sentiment over economic conditions vacillated between hope and despair, as economic reports continued to relay mixed messages. last week's reports were bordering on negative, with the bulk of the negativity stemming from weak readings on the employment front.
www.nasdaq.com

Hl:business Staffing Plans For Friday, Sept. 5, 2008@
business editors:@ here are canadian press business staffing plans as of 4:30 p.m. et. plans may change as circumstances warrant. queries should be addressed to assistant business editor andrew flynn at 416-507-2016 or david paddon on the business desk at 416-507-2138.
news.ino.com

Is Blanket Risk Aversion Killing A High-value Us Industry? - Business24-7
list the markets in which americans have stayed competitive in the past couple of decades and biotechnology drugs would be close to the top. genentech, amgen, genzyme, biogen and gilead have built on the best-funded university research in the world ...
www.business24-7.ae